Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Lannett Company Inc. recalls Niacin Extended-release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications
Products
  • Niacin Extended-release Tablets
Where it was sold

Nationwide in the USA

Nationwide

Units affected
46,848 90-count bottles
About this recall
Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46